P&G Health Q3 FY26 revenue up 20%; board declares Rs 160 interim dividend
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Revenue from operations rose to Rs 373.86 cr in Q3 FY26, up about 20.7% from Rs 309.77 cr in Q3 last year. For nine months FY26, revenue grew to Rs 1,037.5 cr. Net profit for the quarter was Rs 77.59 cr versus Rs 90.90 cr last year, though nine-month PAT grew to Rs 232.31 cr. Board declared an interim dividend of Rs 160 per share including a one-time special dividend of Rs 50. Record date is Feb 12, 2026.
Strong top-line growth and special dividend should support the stock; the Q3 profit dip versus last year is a watch point.